SCHEMBL4903204

SCHEMBL4903204

Cc1cnn(-c2cccc(Nc3ccc(-c4ccccc4)cn3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP1A2 P05177 2/20 0.40
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KDR P35968 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KCNH2 Q12809 1/20 0.36
CACNA1C Q13936 1/20 0.36
ASIC3 Q9UHC3 1/20 0.36
GRM5 P41594 1/20 0.36
CTSC P53634 1/20 0.36
ACHE P22303 1/20 0.36
CYP2C9 P11712 1/20 0.35
HTR3A P46098 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895051 0.89 ALDH1A1 (0.45) KDM4EMAPTMAPK1NPSR1L3MBTL1
Hydrochloric Acid SCHEMBL4896673 0.88 ALDH1A1 (0.45) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL3128924 0.87 KDM4E (0.42) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL5332280 0.84 EGLN1 (0.50) MAPTNPSR1GRM5EGLN1
SCHEMBL4896598 0.83 ALDH1A1 (0.43) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL4899608 0.83 CYP1A2 (0.41) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL4899881 0.83 TSHR (0.39) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL4904831 0.81 ALDH1A1 (0.39) KDM4EMAPTMAPK1NPSR1CYP1A2
SCHEMBL4896551 0.81 ADORA2A (0.41) KDM4EMAPTMAPK1NPSR1L3MBTL1
Hydrochloric Acid SCHEMBL4904519 0.80 ALDH1A1 (0.38) KDM4EMAPTNPSR1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 KDM4E 542/4885MAPT 2710/4885MAPK1 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.